Texas Biomed with the University of Alabama at Birmingham and Aridis Pharmaceuticals develop a neutralizing human monoclonal antibody against SARS-CoV-2

Home > News
By CryptoLTC in News
Updated 3 years ago

Texas Biomedical Research Institute (Texas Biomed) Professor Luis Martinez-Sobrido, Ph.D., recently released study findings, alongside colleagues at the Univers

texas-biomed-with-the-university-of-alabama-at-birmingham-and-aridis-pharmaceuticals-develop-a-neutralizing-human-monoclonal-antibody-against-sarscov2